Mechanisms of Shexiang Baoxin Pill in homo-therapy for heteropathy in type 2 diabetes mellitus and coronary heart disease based on network pharmacology
10.12206/j.issn.2097-2024.202305037
- VernacularTitle:麝香保心丸“异病同治”2型糖尿病和冠心病的网络药理学作用机制研究
- Author:
Zifan ZHU
1
;
Zhicong WANG
1
;
Bin XIE
2
;
Runhui LIU
2
,
3
Author Information
1. Fujian University of Traditional Chinese Medicine, Fuzhou 350122， China.
2. School of Pharmacy，Naval Medical University, Shanghai 200433，China.
3. Fujian University of Traditional Chinese Medicine, Fuzhou 350122， China
- Keywords:
Shexiang Baoxin Pill;
type 2 diabetes mellitus;
coronary heart disease;
homo-therapy for heteropathy;
network pharmacology
- From:
Journal of Pharmaceutical Practice and Service
2024;42(4):173-180
- CountryChina
- Language:Chinese
-
Abstract:
Objective To probe into the mechanism of Shexiang Baoxin Pill in homo-therapy for heteropathy for type 2 diabetes mellitus （T2DM） and coronary heart disease （CHD） based on network pharmacology. Methods All chemical components and action targets of these seven traditional Chinese medical in Shexiang Baoxin Pill were screened by Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform （TCMSP）, Traditional Chinese Medicines Integrated Database （TCMID）, The Encyclopedia of Traditional Chinese Medicine （ETCM） and BATMAN-TCM platform, and the DisGeNET and GeneCards databases were used to obtain CHD and T2DM-related Disease targets. The “drug-component-target” network map was constructed by Cytoscape 3.8.2 software, the protein-protein interaction （PPI） network map was constructed by STRING database, and the GO biological process analysis and KEGG pathway enrichment analysis were performed on the common targets of Shexiang Baoxin Pill for T2DM and CHD using DAVID online database. Results A total of 101 potential active ingredients for the treatment of T2DM and CHD in Shexiang Baoxin Pill were screened out, corresponding to 229 targets. Network analysis results showed that the common main active ingredients in Shexiang Baoxin Pill for treating T2DM and CHD might be chenodeoxycholic acid, ursodeoxycholic acid, cinnamic aldehyde, bile acids, cinnamic acid, and ginsenosides. The results of pathway enrichment analysis showed that the mechanism of action of Shexiang Baoxin Pill in the treatment of type 2 diabetes and coronary heart disease in treating T2DM and CHD might be related to the inhibition of inflammatory response and oxidative stress. Conclusion Shexiang Baoxin Pill could play a role in treating CHD and T2DM through multiple components, multiple targets and multiple pathways, which provided a certain theoretical basis for the clinical application and further research of Shexiang Baoxin Pill.
